arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Stryker Corporation

SYK Health Care Medical/Dental Instruments
$303.13
▼ -0.0% Today
as of Sep 4, 16:55 ET
Last 30 days -12.54% Jul 28 → Sep 04
$299.20 $313.45 $327.69 $341.93 $356.18 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$304.49
High
$307.55
Low
$302.51
Volume
$2M
Avg Vol
$2M
Mkt Cap
$129.4B
P/E (TTM)
63.23
Beta
—
52w High
$396.37
52w Low
$281.00
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 25 items

mixed ▲ 3 ● 22 ▼ 0
Sep 4 · 22:32 PR GlobeNewswire neutral
Schedule update: Stryker to participate in the 2026 Wells Fargo Healthcare Conference
Sep 4 · 18:36 Insider Monkey neutral
Stryker (SYK) is Buying ZuriMED. Can FiberLocker Strengthen its Shoulder Portfolio?
Sep 4 · 14:45 24/7 Wall St. neutral
Intuitive Surgical Vs. Stryker: Wall Street Loves Both But One Has a Quiet Advantage That Will Make Investors Money
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$281
$396
19% of range
Avg surprise (last 2)
+3.2%
Avg reaction (last 1)
+0.0%
100% positive
Latest IV / EM
28%
EM ±4.4% · $310 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$1.93$2.27$2.61$2.96$3.30 Actual $2.84Est $2.73Actual $3.13Est $3.06Actual $1.93Actual $3.30 Mar/2025Jun/2025MarJun
Revenue vs Net Income Revenue Net income
$0$1.7B$3.5B$5.2B$6.9B Mar 25Jun 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $3.30 — — — — financials
Tue Mar 31, 2026Mar 2026 $1.93 — — — — financials
Thu Jul 31, 2025Jun/2025 $3.13 $3.06 +2.3% — — earnings
Thu May 1, 2025Mar/2025 $2.84 $2.73 +4.0% — +0.0% earnings

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$6.59B$6.02B——$6.02B$5.87B——
Cost of revenue$2.09B$2.21B—$2.21B$2.18B$2.12B—$1.98B
Gross profit$4.50B$3.81B——$3.84B$3.74B——
Operating income$1.66B$936M—$1.14B$1.11B$837M—$1.08B
Net income$1.28B$745M——$884M$654M——
EPS (diluted)$3.30$1.93——$2.29$1.69——

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$3.39B$2.88B$4.01B$3.26B$2.38B$2.32B$3.65B$3.85B
Inventory$5.52B$5.42B$5.31B$5.37B$5.29B$5.11B$4.77B$5.29B
Total current assets$14.42B$13.34B$14.76B$13.71B$13.00B$13.02B$14.85B$14.67B
Total assets$47.93B$46.29B$47.84B$47.06B$46.33B$46.01B$42.97B$43.83B
Long-term debt$14.19B$14.22B$14.86B$14.85B$14.83B$14.38B$12.19B$13.32B
Total liabilities$23.94B$23.31B$25.42B$25.27B$25.14B$25.08B$22.34B$23.68B
Total equity$23.99B$22.98B$22.42B$21.79B$21.19B$20.93B—$20.15B

Implied volatility — last 90 days

25%33%41%49%57% Jun 07 — IV 35% · EM ±4.8%Jun 08 — IV 34% · EM ±4.5%Jun 09 — IV 34% · EM ±4.3%Jun 10 — IV 36% · EM ±4.2%Jun 11 — IV 35% · EM ±3.9%Jun 12 — IV 31% · EM ±3.2%Jun 15 — IV 33% · EM ±2.4%Jun 16 — IV 35% · EM ±2.1%Jun 17 — IV 47% · EM ±2.0%Jun 19 — IV 30% · EM ±6.5%Jun 22 — IV 30% · EM ±6.2%Jun 23 — IV 29% · EM ±6.0%Jun 24 — IV 30% · EM ±6.1%Jun 25 — IV 29% · EM ±5.6%Jun 26 — IV 29% · EM ±5.5%Jun 29 — IV 30% · EM ±5.3%Jun 30 — IV 31% · EM ±5.3%Jul 01 — IV 32% · EM ±5.3%Jul 02 — IV 32% · EM ±5.1%Jul 03 — IV 33% · EM ±5.1%Jul 06 — IV 34% · EM ±4.7%Jul 07 — IV 33% · EM ±4.3%Jul 08 — IV 32% · EM ±4.0%Jul 09 — IV 31% · EM ±3.7%Jul 10 — IV 29% · EM ±3.2%Jul 13 — IV 37% · EM ±3.1%Jul 14 — IV 42% · EM ±3.0%Jul 15 — IV 57% · EM ±3.4%Jul 16 — IV 54% · EM ±2.2%Jul 20 — IV 39% · EM ±9.2%Jul 21 — IV 39% · EM ±9.0%Jul 22 — IV 38% · EM ±8.6%Jul 23 — IV 38% · EM ±8.5%Jul 24 — IV 37% · EM ±8.2%Jul 27 — IV 39% · EM ±8.1%Jul 28 — IV 39% · EM ±7.9%Jul 29 — IV 40% · EM ±8.0%Jul 30 — IV 57% · EM ±11.2%Jul 31 — IV 32% · EM ±6.0%Aug 03 — IV 33% · EM ±5.9%Aug 04 — IV 37% · EM ±6.3%Aug 05 — IV 35% · EM ±5.8%Aug 06 — IV 34% · EM ±5.4%Aug 07 — IV 30% · EM ±4.6%Aug 10 — IV 33% · EM ±4.5%Aug 11 — IV 27% · EM ±3.5%Aug 12 — IV 30% · EM ±3.7%Aug 13 — IV 27% · EM ±3.2%Aug 14 — IV 27% · EM ±3.0%Aug 17 — IV 29% · EM ±2.5%Aug 18 — IV 32% · EM ±2.3%Aug 19 — IV 31% · EM ±1.9%Aug 20 — IV 39% · EM ±1.6%Aug 24 — IV 27% · EM ±5.7%Aug 25 — IV 27% · EM ±5.6%Aug 26 — IV 29% · EM ±5.7%Aug 27 — IV 27% · EM ±5.3%Aug 28 — IV 25% · EM ±4.8%Aug 31 — IV 28% · EM ±5.0%Sep 01 — IV 27% · EM ±4.7%Sep 02 — IV 28% · EM ±4.8%Sep 03 — IV 27% · EM ±4.3%Sep 04 — IV 28% · EM ±4.4%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in